US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tempest Therapeutics Inc.

9.92

+0.07000.71%

Post-market: 10.000.0800+0.81%19:13 EDT

Volume:25.64K

Turnover:254.53K

Market Cap:44.05M

PE:-0.51

High:10.42

Open:10.03

Low:9.73

Close:9.85

52wk High:20.67

52wk Low:5.35

Shares:4.44M

Float Shares:4.16M

Volume Ratio:0.30

T/O Rate:0.62%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-19.4955

EPS(LYR):-19.4955

ROE:-322.57%

ROA:-81.34%

PB:4.50

PE(LYR):-0.51

Loading ...

Overview Company News Filings

Tempest Therapeutics Cut to Sector Perform From Sector Outperform by Scotiabank

HC Wainwright Downgrades Tempest Therapeutics to Neutral From Buy

MT Newswires Live

BUZZ-Tempest rises as company eyes potential merger to advance liver cancer drug

Tempest Therapeutics Seeks Partner as It Explores Strategic Alternatives

Tempest Therapeutics to explore strategic alternatives

Tempest Announces Plan to Explore Strategic Alternatives to Advance Promising Pipeline of Clinical Oncology Assets and Maximize Stockholder Value

BRIEF-Tempest Therapeutics Announced 1-For-13 Reverse Stock Split

Tempest Therapeutics treatment of FAP granted FDA orphan designation

Scotiabank Reaffirms Their Buy Rating on Tempest Therapeutics (TPST)

Piper Sandler Reaffirms Their Buy Rating on Tempest Therapeutics (TPST)

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Kodiak Sciences (KOD), Tempest Therapeutics (TPST) and EDAP TMS (EDAP)

Tempest Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

William Blair Reaffirms Their Buy Rating on Tempest Therapeutics (TPST)

Press Release: Tempest Reports Year End 2024 Financial Results and Provides Business Update

Jakarta to Deploy Nearly 3,000 Sanitation Officers to Anticipate Eid Holiday

Tempest Therapeutics Inc expected to post a loss of 25 cents a share - Earnings Preview

Tempest Therapeutics Says Familial Adenomatous Polyposis Trial Gets US FDA 'Study May Proceed' Notice

MT Newswires Live

BRIEF-Tempest gets FDA nod to begin mid-stage study of its therapy for colon cancer-causing genertic condition

FDA Study May Proceed Notice Received for Phase 2 Trial of TPST-1495 for the Treatment of Familial Adenomatous Polyposis (FAP)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/TPST/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TPST","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TPST\",,,,,undefined,":{"symbol":"TPST","market":"US","secType":"STK","nameCN":"Tempest Therapeutics Inc.","latestPrice":9.92,"timestamp":1756497600000,"preClose":9.85,"halted":0,"volume":25637,"hourTrading":{"tag":"盘后","latestPrice":10,"preClose":9.92,"latestTime":"19:13 EDT","volume":243,"amount":2417.76009,"timestamp":1756509237938},"delay":0,"floatShares":4163800,"shares":4440161,"eps":-19.49552,"marketStatus":"Post-Mkt","change":0.07,"latestTime":"08-29 19:21:20 EDT","open":10.03,"high":10.4156,"low":9.7289,"amount":254530.442702,"amplitude":0.069716,"askPrice":11.3,"askSize":45,"bidPrice":10,"bidSize":345,"shortable":3,"etf":0,"ttmEps":-19.49552,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1756512000000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":9.85,"preHourTrading":{"tag":"盘前","latestPrice":10.31,"preClose":9.85,"latestTime":"09:20 EDT","volume":360,"amount":3665.0905199999997,"timestamp":1756473653026},"postHourTrading":{"tag":"盘后","latestPrice":10,"preClose":9.92,"latestTime":"19:13 EDT","volume":243,"amount":2417.76009,"timestamp":1756509237938},"volumeRatio":0.295527,"impliedVol":1.4125,"impliedVolPercentile":0.3618},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TPST\",,,,,undefined,":{"symbol":"TPST","floatShares":4163800,"roa":"-81.34%","roe":"-322.57%","lyrEps":-19.495519,"volumeRatio":0.295527,"shares":4440161,"dividePrice":0,"high":10.4156,"amplitude":0.069716,"preClose":9.85,"low":9.7289,"week52Low":5.3495,"pbRate":"4.50","week52High":20.67,"institutionHeld":0,"latestPrice":9.92,"committee":0.769231,"eps":-19.49552,"divideRate":0,"volume":25637,"delay":0,"ttmEps":-19.49552,"open":10.03,"prevYearClose":10.8485,"prevWeekClose":10.025,"prevMonthClose":7.23,"prevQuarterClose":6.8,"fiveDayClose":10.025,"twentyDayClose":7.49,"sixtyDayClose":6.895},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TPST\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-08-11","symbol":"TPST","fiscalQuarterEnding":"2025/06","expectedEps":-3.23,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754884800000,"reportTimeType":"post","actualEps":-2.07},{"market":"US","date":"2025-05-13","symbol":"TPST","fiscalQuarterEnding":"2025/03","expectedEps":-3.71,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747108800000,"reportTimeType":"post","actualEps":-3.16},{"market":"US","date":"2025-04-09","symbol":"TPST","defaultRemindTime":1744205400000,"type":"split","dateTimestamp":1744171200000,"forFactor":13,"toFactor":1,"ratio":13},{"market":"US","date":"2025-03-27","symbol":"TPST","fiscalQuarterEnding":"2024/12","expectedEps":-0.24,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1743048000000,"reportTimeType":"post","actualEps":-0.31},{"market":"US","date":"2024-11-12","symbol":"TPST","fiscalQuarterEnding":"2024/09","expectedEps":-0.37,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"post","actualEps":-0.41}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TPST\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TPST\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":1,"updateTime":1744344000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TPST\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TPST","date":"2025-08-28","current":-1.108521,"percent":0.364798,"low":-8.356309,"twenty":-2.389034,"median":-0.92015,"eighty":-0.546796,"high":-0.092119,"avg":-1.409819,"sd":1.256496,"marketCap":47776132},"quantilePoints":[{"date":"2021-07-02","current":-3.87589,"twenty":-4.366422,"median":-3.87589,"eighty":-3.854472,"marketCap":74448099},{"date":"2021-07-09","current":-5.413119,"twenty":-4.59027,"median":-3.87589,"eighty":-3.804729,"marketCap":103975198},{"date":"2021-07-16","current":-6.460733,"twenty":-6.872278,"median":-4.594416,"eighty":-3.846873,"marketCap":131378999},{"date":"2021-07-23","current":-4.897757,"twenty":-6.578857,"median":-5.413119,"eighty":-3.870363,"marketCap":99595898},{"date":"2021-07-30","current":-4.90102,"twenty":-6.47248,"median":-5.100063,"eighty":-4.132901,"marketCap":99662251},{"date":"2021-08-06","current":-4.437675,"twenty":-6.094624,"median":-4.90102,"eighty":-4.167499,"marketCap":90240120},{"date":"2021-08-13","current":-4.017168,"twenty":-5.844679,"median":-4.788448,"eighty":-4.137999,"marketCap":89036517},{"date":"2021-08-20","current":-4.092679,"twenty":-5.613659,"median":-4.573689,"eighty":-4.006294,"marketCap":90710136},{"date":"2021-08-27","current":-4.491375,"twenty":-5.432774,"median":-4.470305,"eighty":-4.062475,"marketCap":99546843},{"date":"2021-09-03","current":-4.497416,"twenty":-5.260526,"median":-4.45399,"eighty":-4.099928,"marketCap":99680732},{"date":"2021-09-10","current":-4.415865,"twenty":-5.154881,"median":-4.430967,"eighty":-4.108385,"marketCap":97873224},{"date":"2021-09-17","current":-4.566886,"twenty":-5.109852,"median":-4.445832,"eighty":-4.118064,"marketCap":101220462},{"date":"2021-09-24","current":-4.394722,"twenty":-5.010657,"median":-4.45399,"eighty":-4.133475,"marketCap":97404611},{"date":"2021-10-01","current":-4.560845,"twenty":-4.930387,"median":-4.456071,"eighty":-4.166713,"marketCap":101086572},{"date":"2021-10-08","current":-4.545743,"twenty":-4.899715,"median":-4.458151,"eighty":-4.233331,"marketCap":100751848},{"date":"2021-10-15","current":-4.433987,"twenty":-4.857296,"median":-4.467212,"eighty":-4.295101,"marketCap":98274893},{"date":"2021-10-22","current":-3.669819,"twenty":-4.790079,"median":-4.437675,"eighty":-4.197085,"marketCap":81337871},{"date":"2021-10-29","current":-3.539941,"twenty":-4.772251,"median":-4.429457,"eighty":-4.108385,"marketCap":78459247},{"date":"2021-11-05","current":-3.684921,"twenty":-4.721532,"median":-4.415865,"eighty":-4.000858,"marketCap":81672595},{"date":"2021-11-12","current":-3.187711,"twenty":-4.644181,"median":-4.385661,"eighty":-3.839273,"marketCap":79192313},{"date":"2021-11-19","current":-2.940149,"twenty":-4.605505,"median":-4.370558,"eighty":-3.725999,"marketCap":73042124},{"date":"2021-11-26","current":-2.670362,"twenty":-4.588029,"median":-4.369152,"eighty":-3.677672,"marketCap":66339801},{"date":"2021-12-03","current":-2.27952,"twenty":-4.575947,"median":-4.350925,"eighty":-3.614688,"marketCap":56630105},{"date":"2021-12-10","current":-2.144612,"twenty":-4.575495,"median":-4.328272,"eighty":-3.540545,"marketCap":53278598},{"date":"2021-12-17","current":-1.860889,"twenty":-4.573537,"median":-4.308706,"eighty":-3.196056,"marketCap":46230067},{"date":"2021-12-23","current":-1.696775,"twenty":-4.572927,"median":-4.273905,"eighty":-3.006907,"marketCap":42152976},{"date":"2021-12-31","current":-1.468684,"twenty":-4.566886,"median":-4.198394,"eighty":-2.781598,"marketCap":36486510},{"date":"2022-01-07","current":-1.286489,"twenty":-4.563866,"median":-4.135737,"eighty":-2.670362,"marketCap":31960248},{"date":"2022-01-14","current":-1.143237,"twenty":-4.560845,"median":-4.104761,"eighty":-2.308726,"marketCap":28401431},{"date":"2022-01-21","current":-1.015283,"twenty":-4.548763,"median":-4.092679,"eighty":-2.166865,"marketCap":25222682},{"date":"2022-01-28","current":-1.029191,"twenty":-4.533661,"median":-3.941657,"eighty":-1.923197,"marketCap":25568198},{"date":"2022-02-04","current":-0.997203,"twenty":-4.504061,"median":-3.862072,"eighty":-1.849206,"marketCap":24773511},{"date":"2022-02-11","current":-0.904019,"twenty":-4.497416,"median":-3.798275,"eighty":-1.518753,"marketCap":22458553},{"date":"2022-02-18","current":-0.915146,"twenty":-4.495,"median":-3.697003,"eighty":-1.468684,"marketCap":22734965},{"date":"2022-02-25","current":-0.88733,"twenty":-4.494396,"median":-3.684921,"eighty":-1.297337,"marketCap":22043933},{"date":"2022-03-04","current":-0.792755,"twenty":-4.492583,"median":-3.669819,"eighty":-1.208326,"marketCap":19694423},{"date":"2022-03-11","current":-0.639768,"twenty":-4.488522,"median":-3.612431,"eighty":-1.090943,"marketCap":15893745},{"date":"2022-03-18","current":-0.737123,"twenty":-4.485848,"median":-3.547492,"eighty":-1.043667,"marketCap":18312358},{"date":"2022-03-25","current":-1.059789,"twenty":-4.479897,"median":-3.470471,"eighty":-1.023628,"marketCap":26328334},{"date":"2022-04-01","current":-0.811035,"twenty":-4.4654,"median":-3.208573,"eighty":-1.008051,"marketCap":22953900},{"date":"2022-04-08","current":-0.940293,"twenty":-4.455654,"median":-3.068103,"eighty":-0.990805,"marketCap":26612178},{"date":"2022-04-14","current":-0.864259,"twenty":-4.447464,"median":-3.004126,"eighty":-0.978227,"marketCap":24460250},{"date":"2022-04-22","current":-0.608276,"twenty":-4.4362,"median":-2.809414,"eighty":-0.949261,"marketCap":17215425},{"date":"2022-04-29","current":-0.914948,"twenty":-4.432779,"median":-2.69815,"eighty":-0.927385,"marketCap":25894869},{"date":"2022-05-06","current":-0.780621,"twenty":-4.429759,"median":-2.634187,"eighty":-0.919596,"marketCap":22093129},{"date":"2022-05-13","current":-0.945679,"twenty":-4.423114,"median":-2.372731,"eighty":-0.91006,"marketCap":29730257},{"date":"2022-05-20","current":-1.175532,"twenty":-4.415865,"median":-2.292733,"eighty":-0.915027,"marketCap":36956361},{"date":"2022-05-27","current":-0.929261,"twenty":-4.411032,"median":-2.144612,"eighty":-0.915146,"marketCap":29214106},{"date":"2022-06-03","current":-1.024486,"twenty":-4.401971,"median":-1.961027,"eighty":-0.917312,"marketCap":32207778},{"date":"2022-06-10","current":-0.87344,"twenty":-4.391097,"median":-1.89844,"eighty":-0.914988,"marketCap":27459195},{"date":"2022-06-17","current":-0.68299,"twenty":-4.375995,"median":-1.860889,"eighty":-0.904575,"marketCap":21471852},{"date":"2022-06-24","current":-0.791349,"twenty":-4.373579,"median":-1.696775,"eighty":-0.88733,"marketCap":24878444},{"date":"2022-07-01","current":-0.751946,"twenty":-4.370558,"median":-1.518753,"eighty":-0.874397,"marketCap":23639683},{"date":"2022-07-08","current":-0.820902,"twenty":-4.370558,"median":-1.515971,"eighty":-0.858958,"marketCap":25807515},{"date":"2022-07-15","current":-0.817618,"twenty":-4.369433,"median":-1.468684,"eighty":-0.850746,"marketCap":25704284},{"date":"2022-07-22","current":-0.742095,"twenty":-4.360612,"median":-1.295529,"eighty":-0.825088,"marketCap":23329993},{"date":"2022-07-29","current":-0.666572,"twenty":-4.353644,"median":-1.267473,"eighty":-0.816961,"marketCap":20955702},{"date":"2022-08-05","current":-0.748663,"twenty":-4.350019,"median":-1.244766,"eighty":-0.807767,"marketCap":23536453},{"date":"2022-08-12","current":-0.705976,"twenty":-4.349415,"median":-1.195233,"eighty":-0.794257,"marketCap":22194462},{"date":"2022-08-19","current":-0.789147,"twenty":-4.332501,"median":-1.155754,"eighty":-0.792474,"marketCap":26474313},{"date":"2022-08-26","current":-0.717407,"twenty":-4.328272,"median":-1.09595,"eighty":-0.788837,"marketCap":24067557},{"date":"2022-09-02","current":-0.667716,"twenty":-4.31619,"median":-1.078008,"eighty":-0.778189,"marketCap":22400540},{"date":"2022-09-09","current":-0.826105,"twenty":-4.307813,"median":-1.058398,"eighty":-0.778163,"marketCap":27714156},{"date":"2022-09-16","current":-0.70809,"twenty":-4.295101,"median":-1.045881,"eighty":-0.772644,"marketCap":23754991},{"date":"2022-09-23","current":-0.531067,"twenty":-4.270884,"median":-1.034295,"eighty":-0.753916,"marketCap":17816243},{"date":"2022-09-30","current":-0.540384,"twenty":-4.23343,"median":-1.024486,"eighty":-0.749589,"marketCap":18128809},{"date":"2022-10-07","current":-0.527962,"twenty":-4.205643,"median":-1.013892,"eighty":-0.742095,"marketCap":17712055},{"date":"2022-10-14","current":-0.493799,"twenty":-4.197085,"median":-1.008068,"eighty":-0.732385,"marketCap":16565981},{"date":"2022-10-21","current":-0.540384,"twenty":-4.166713,"median":-0.995116,"eighty":-0.723215,"marketCap":18128809},{"date":"2022-10-28","current":-0.605603,"twenty":-4.133475,"median":-0.988448,"eighty":-0.71911,"marketCap":20316769},{"date":"2022-11-04","current":-0.599392,"twenty":-4.118064,"median":-0.98669,"eighty":-0.715385,"marketCap":20108392},{"date":"2022-11-11","current":-0.492439,"twenty":-4.108385,"median":-0.975776,"eighty":-0.70809,"marketCap":16932529},{"date":"2022-11-18","current":-0.521496,"twenty":-4.099324,"median":-0.96416,"eighty":-0.70089,"marketCap":17931653},{"date":"2022-11-25","current":-0.516908,"twenty":-4.094491,"median":-0.952136,"eighty":-0.69569,"marketCap":17773897},{"date":"2022-12-02","current":-0.516908,"twenty":-4.062475,"median":-0.945743,"eighty":-0.689451,"marketCap":17773897},{"date":"2022-12-09","current":-0.492439,"twenty":-4.006294,"median":-0.942986,"eighty":-0.683518,"marketCap":16932529},{"date":"2022-12-16","current":-0.415974,"twenty":-3.951323,"median":-0.932545,"eighty":-0.669791,"marketCap":14303254},{"date":"2022-12-23","current":-0.389486,"twenty":-3.886355,"median":-0.927663,"eighty":-0.664265,"marketCap":13392473},{"date":"2022-12-30","current":-0.351742,"twenty":-3.873126,"median":-0.920562,"eighty":-0.656845,"marketCap":12094663},{"date":"2023-01-06","current":-0.403739,"twenty":-3.862072,"median":-0.915047,"eighty":-0.639768,"marketCap":13882570},{"date":"2023-01-13","current":-0.529143,"twenty":-3.824074,"median":-0.906801,"eighty":-0.608276,"marketCap":18194581},{"date":"2023-01-20","current":-0.60255,"twenty":-3.821487,"median":-0.904019,"eighty":-0.601918,"marketCap":20718685},{"date":"2023-01-27","current":-0.62396,"twenty":-3.784737,"median":-0.891877,"eighty":-0.599302,"marketCap":21454881},{"date":"2023-02-03","current":-0.611726,"twenty":-3.770737,"median":-0.887069,"eighty":-0.599302,"marketCap":21034198},{"date":"2023-02-10","current":-0.565847,"twenty":-3.711501,"median":-0.873919,"eighty":-0.589454,"marketCap":19456633},{"date":"2023-02-17","current":-0.541377,"twenty":-3.687337,"median":-0.859514,"eighty":-0.578026,"marketCap":18615265},{"date":"2023-02-24","current":-0.504674,"twenty":-3.684921,"median":-0.856732,"eighty":-0.574546,"marketCap":17353213},{"date":"2023-03-03","current":-0.498557,"twenty":-3.679484,"median":-0.853912,"eighty":-0.568155,"marketCap":17142871},{"date":"2023-03-10","current":-0.382329,"twenty":-3.672235,"median":-0.848387,"eighty":-0.564253,"marketCap":13146373},{"date":"2023-03-17","current":-0.370094,"twenty":-3.669819,"median":-0.828444,"eighty":-0.553309,"marketCap":12725689},{"date":"2023-03-24","current":-0.402249,"twenty":-3.642157,"median":-0.820902,"eighty":-0.543212,"marketCap":14363912},{"date":"2023-03-31","current":-0.68619,"twenty":-3.616945,"median":-0.820902,"eighty":-0.54098,"marketCap":24503144},{"date":"2023-04-06","current":-0.691011,"twenty":-3.602766,"median":-0.818755,"eighty":-0.542601,"marketCap":24675299},{"date":"2023-04-14","current":-0.919849,"twenty":-3.57377,"median":-0.819893,"eighty":-0.5453,"marketCap":32846887},{"date":"2023-04-21","current":-0.65957,"twenty":-3.548398,"median":-0.818755,"eighty":-0.546796,"marketCap":23552591},{"date":"2023-04-28","current":-0.508727,"twenty":-3.542357,"median":-0.812709,"eighty":-0.544868,"marketCap":18166124},{"date":"2023-05-05","current":-0.635908,"twenty":-3.526047,"median":-0.809409,"eighty":-0.546696,"marketCap":22707655},{"date":"2023-05-12","current":-0.627035,"twenty":-3.425045,"median":-0.799677,"eighty":-0.548239,"marketCap":22390804},{"date":"2023-05-19","current":-0.684799,"twenty":-3.240561,"median":-0.794633,"eighty":-0.552974,"marketCap":23867996},{"date":"2023-05-26","current":-0.681475,"twenty":-3.22109,"median":-0.792755,"eighty":-0.555339,"marketCap":23752132},{"date":"2023-06-02","current":-0.478695,"twenty":-3.187711,"median":-0.790248,"eighty":-0.547097,"marketCap":16684424},{"date":"2023-06-09","current":-0.445452,"twenty":-3.076447,"median":-0.788837,"eighty":-0.540384,"marketCap":15525784},{"date":"2023-06-16","current":-0.472046,"twenty":-3.068103,"median":-0.784763,"eighty":-0.53526,"marketCap":16452696},{"date":"2023-06-23","current":-0.398912,"twenty":-3.019146,"median":-0.779418,"eighty":-0.531975,"marketCap":13903687},{"date":"2023-06-30","current":-0.388939,"twenty":-3.005238,"median":-0.775697,"eighty":-0.53006,"marketCap":13556095},{"date":"2023-07-07","current":-0.393527,"twenty":-2.978535,"median":-0.772478,"eighty":-0.526835,"marketCap":13715987},{"date":"2023-07-14","current":-0.382291,"twenty":-2.898981,"median":-0.758513,"eighty":-0.523758,"marketCap":13324366},{"date":"2023-07-21","current":-0.345724,"twenty":-2.814977,"median":-0.751946,"eighty":-0.521598,"marketCap":12049862},{"date":"2023-07-28","current":-0.323434,"twenty":-2.770472,"median":-0.750207,"eighty":-0.516908,"marketCap":11272982},{"date":"2023-08-04","current":-0.305833,"twenty":-2.731529,"median":-0.742916,"eighty":-0.508659,"marketCap":10659493},{"date":"2023-08-11","current":-0.20278,"twenty":-2.697037,"median":-0.742095,"eighty":-0.503739,"marketCap":7067707},{"date":"2023-08-18","current":-0.256332,"twenty":-2.685366,"median":-0.735029,"eighty":-0.497566,"marketCap":8527401},{"date":"2023-08-25","current":-0.244317,"twenty":-2.641422,"median":-0.724862,"eighty":-0.492439,"marketCap":8127679},{"date":"2023-09-01","current":-0.215479,"twenty":-2.519015,"median":-0.723215,"eighty":-0.489906,"marketCap":7168346},{"date":"2023-09-08","current":-0.18508,"twenty":-2.394961,"median":-0.722394,"eighty":-0.486791,"marketCap":6157050},{"date":"2023-09-15","current":-0.198257,"twenty":-2.35993,"median":-0.71911,"eighty":-0.47936,"marketCap":6595412},{"date":"2023-09-22","current":-0.191648,"twenty":-2.30817,"median":-0.717407,"eighty":-0.473701,"marketCap":6375565},{"date":"2023-09-29","current":-0.134174,"twenty":-2.30066,"median":-0.714724,"eighty":-0.469183,"marketCap":4463561},{"date":"2023-10-06","current":-0.106138,"twenty":-2.258102,"median":-0.713631,"eighty":-0.462795,"marketCap":3530877},{"date":"2023-10-13","current":-1.594066,"twenty":-2.172428,"median":-0.710317,"eighty":-0.462073,"marketCap":53029778},{"date":"2023-10-20","current":-2.43115,"twenty":-2.308726,"median":-0.714724,"eighty":-0.462073,"marketCap":80877074},{"date":"2023-10-27","current":-1.702206,"twenty":-2.307614,"median":-0.714724,"eighty":-0.462303,"marketCap":56627276},{"date":"2023-11-03","current":-1.537993,"twenty":-2.295375,"median":-0.717407,"eighty":-0.462942,"marketCap":51164409},{"date":"2023-11-10","current":-1.404968,"twenty":-2.236683,"median":-0.71911,"eighty":-0.463994,"marketCap":43702933},{"date":"2023-11-17","current":-2.035757,"twenty":-2.161302,"median":-0.722394,"eighty":-0.466135,"marketCap":63324258},{"date":"2023-11-24","current":-2.425583,"twenty":-2.30066,"median":-0.723215,"eighty":-0.46812,"marketCap":75450180},{"date":"2023-12-01","current":-2.174981,"twenty":-2.308726,"median":-0.724039,"eighty":-0.468722,"marketCap":67654944},{"date":"2023-12-08","current":-2.011006,"twenty":-2.305945,"median":-0.732935,"eighty":-0.471029,"marketCap":62554358},{"date":"2023-12-15","current":-2.530774,"twenty":-2.308726,"median":-0.740453,"eighty":-0.472046,"marketCap":78722254},{"date":"2023-12-22","current":-2.289453,"twenty":-2.312013,"median":-0.742095,"eighty":-0.472052,"marketCap":71215731},{"date":"2023-12-29","current":-2.821596,"twenty":-2.338955,"median":-0.742095,"eighty":-0.47206,"marketCap":87768577},{"date":"2024-01-05","current":-2.512211,"twenty":-2.379021,"median":-0.7462,"eighty":-0.472359,"marketCap":78144829},{"date":"2024-01-12","current":-2.5679,"twenty":-2.42781,"median":-0.751946,"eighty":-0.475986,"marketCap":79877104},{"date":"2024-01-19","current":-2.481272,"twenty":-2.499835,"median":-0.751946,"eighty":-0.478433,"marketCap":77182454},{"date":"2024-01-26","current":-2.258515,"twenty":-2.49241,"median":-0.761252,"eighty":-0.478684,"marketCap":70253356},{"date":"2024-02-02","current":-2.518399,"twenty":-2.49241,"median":-0.773308,"eighty":-0.478695,"marketCap":78337304},{"date":"2024-02-09","current":-2.570994,"twenty":-2.515924,"median":-0.77815,"eighty":-0.480025,"marketCap":79973341},{"date":"2024-02-16","current":-2.462709,"twenty":-2.538199,"median":-0.783794,"eighty":-0.482517,"marketCap":76605030},{"date":"2024-02-23","current":-2.35133,"twenty":-2.528299,"median":-0.788837,"eighty":-0.48368,"marketCap":73140481},{"date":"2024-03-01","current":-2.295641,"twenty":-2.517161,"median":-0.788992,"eighty":-0.485539,"marketCap":71408206},{"date":"2024-03-08","current":-2.165699,"twenty":-2.512211,"median":-0.792755,"eighty":-0.486791,"marketCap":67366232},{"date":"2024-03-15","current":-2.122385,"twenty":-2.509736,"median":-0.794633,"eighty":-0.488694,"marketCap":66018907},{"date":"2024-03-22","current":-2.641281,"twenty":-2.512211,"median":-0.798154,"eighty":-0.488916,"marketCap":77894011},{"date":"2024-03-28","current":-2.791781,"twenty":-2.543149,"median":-0.807471,"eighty":-0.489381,"marketCap":82332416},{"date":"2024-04-05","current":-3.386257,"twenty":-2.570994,"median":-0.81106,"eighty":-0.490694,"marketCap":99864117},{"date":"2024-04-12","current":-2.897131,"twenty":-2.598013,"median":-0.817618,"eighty":-0.490694,"marketCap":85439300},{"date":"2024-04-19","current":-2.38543,"twenty":-2.598013,"median":-0.820902,"eighty":-0.492439,"marketCap":70348722},{"date":"2024-04-26","current":-2.621684,"twenty":-2.598013,"median":-0.826105,"eighty":-0.492439,"marketCap":77316082},{"date":"2024-05-03","current":-2.666885,"twenty":-2.617402,"median":-0.833087,"eighty":-0.492439,"marketCap":78649118},{"date":"2024-05-10","current":-2.61415,"twenty":-2.626683,"median":-0.849052,"eighty":-0.493799,"marketCap":77093909},{"date":"2024-05-17","current":-2.403965,"twenty":-2.621684,"median":-0.856655,"eighty":-0.496905,"marketCap":71539593},{"date":"2024-05-24","current":-2.396499,"twenty":-2.617402,"median":-0.857161,"eighty":-0.496905,"marketCap":71317420},{"date":"2024-05-31","current":-2.448759,"twenty":-2.6148,"median":-0.860695,"eighty":-0.498227,"marketCap":72872629},{"date":"2024-06-07","current":-2.389034,"twenty":-2.61415,"median":-0.872983,"eighty":-0.498557,"marketCap":71095248},{"date":"2024-06-14","current":-2.262116,"twenty":-2.61415,"median":-0.879472,"eighty":-0.498557,"marketCap":67318312},{"date":"2024-06-21","current":-1.500612,"twenty":-2.6105,"median":-0.887069,"eighty":-0.500381,"marketCap":44656702},{"date":"2024-06-28","current":-1.620063,"twenty":-2.606851,"median":-0.887199,"eighty":-0.502204,"marketCap":48211465},{"date":"2024-07-05","current":-1.575269,"twenty":-2.600818,"median":-0.89935,"eighty":-0.504051,"marketCap":46878429},{"date":"2024-07-12","current":-1.620063,"twenty":-2.594796,"median":-0.906801,"eighty":-0.504674,"marketCap":48211465},{"date":"2024-07-15","current":-1.664858,"twenty":-2.593723,"median":-0.906801,"eighty":-0.504674,"marketCap":49544500},{"date":"2024-08-02","current":-1.27664,"twenty":-2.592651,"median":-0.906801,"eighty":-0.504674,"marketCap":37991523},{"date":"2024-08-09","current":-1.000408,"twenty":-2.59155,"median":-0.915047,"eighty":-0.504674,"marketCap":29771135},{"date":"2024-08-16","current":-1.230694,"twenty":-2.59155,"median":-0.914948,"eighty":-0.508613,"marketCap":39072077},{"date":"2024-08-23","current":-1.159234,"twenty":-2.586463,"median":-0.917498,"eighty":-0.508727,"marketCap":36803376},{"date":"2024-08-30","current":-1.071895,"twenty":-2.574088,"median":-0.926272,"eighty":-0.510791,"marketCap":34030519},{"date":"2024-09-06","current":-0.992495,"twenty":-2.573662,"median":-0.929261,"eighty":-0.510791,"marketCap":31509740},{"date":"2024-09-13","current":-1.056015,"twenty":-2.571506,"median":-0.936372,"eighty":-0.515685,"marketCap":33526363},{"date":"2024-09-20","current":-1.119535,"twenty":-2.568519,"median":-0.944855,"eighty":-0.516908,"marketCap":35542986},{"date":"2024-09-27","current":-1.032195,"twenty":-2.558,"median":-0.945679,"eighty":-0.517462,"marketCap":32770129},{"date":"2024-10-04","current":-1.079835,"twenty":-2.547756,"median":-0.947897,"eighty":-0.519494,"marketCap":34282597},{"date":"2024-10-11","current":-0.873396,"twenty":-2.543682,"median":-0.952136,"eighty":-0.52119,"marketCap":27728571},{"date":"2024-10-18","current":-0.913096,"twenty":-2.543149,"median":-0.945743,"eighty":-0.521699,"marketCap":28988960},{"date":"2024-10-25","current":-0.841636,"twenty":-2.539308,"median":-0.945267,"eighty":-0.52175,"marketCap":26720259},{"date":"2024-10-31","current":-0.801294,"twenty":-2.533804,"median":-0.942574,"eighty":-0.522516,"marketCap":25439492},{"date":"2024-11-08","current":-0.88698,"twenty":-2.52636,"median":-0.935828,"eighty":-0.523026,"marketCap":28159839},{"date":"2024-11-15","current":-0.725592,"twenty":-2.523417,"median":-0.929158,"eighty":-0.524124,"marketCap":25771566},{"date":"2024-11-22","current":-0.668373,"twenty":-2.521895,"median":-0.926272,"eighty":-0.525575,"marketCap":23739275},{"date":"2024-11-29","current":-1.167295,"twenty":-2.519888,"median":-0.928976,"eighty":-0.526066,"marketCap":41459968},{"date":"2024-12-06","current":-1.07772,"twenty":-2.516381,"median":-0.930903,"eighty":-0.526084,"marketCap":38278461},{"date":"2024-12-13","current":-1.025499,"twenty":-2.512897,"median":-0.936916,"eighty":-0.526835,"marketCap":36423673},{"date":"2024-12-20","current":-0.884686,"twenty":-2.512211,"median":-0.938605,"eighty":-0.528434,"marketCap":31422291},{"date":"2024-12-27","current":-1.085215,"twenty":-2.511466,"median":-0.942574,"eighty":-0.529143,"marketCap":38544677},{"date":"2025-01-03","current":-1.054743,"twenty":-2.508485,"median":-0.945267,"eighty":-0.529143,"marketCap":37462354},{"date":"2025-01-10","current":-1.211037,"twenty":-2.508485,"median":-0.945711,"eighty":-0.530366,"marketCap":43013626},{"date":"2025-01-17","current":-1.09996,"twenty":-2.501565,"median":-0.951307,"eighty":-0.530672,"marketCap":39068382},{"date":"2025-01-24","current":-1.134979,"twenty":-2.499835,"median":-0.963104,"eighty":-0.530909,"marketCap":40312181},{"date":"2025-01-31","current":-1.161151,"twenty":-2.488697,"median":-0.971969,"eighty":-0.531748,"marketCap":41241758},{"date":"2025-02-07","current":-1.117039,"twenty":-2.479682,"median":-0.981904,"eighty":-0.532314,"marketCap":39675007},{"date":"2025-02-14","current":-1.145423,"twenty":-2.472787,"median":-0.98377,"eighty":-0.533459,"marketCap":40683139},{"date":"2025-02-21","current":-1.114459,"twenty":-2.467659,"median":-0.98669,"eighty":-0.534608,"marketCap":39583359},{"date":"2025-02-28","current":-0.971681,"twenty":-2.464565,"median":-0.988366,"eighty":-0.536484,"marketCap":34512150},{"date":"2025-03-07","current":-1.02255,"twenty":-2.461897,"median":-0.988407,"eighty":-0.539069,"marketCap":36318932},{"date":"2025-03-14","current":-1.024762,"twenty":-2.456542,"median":-0.991095,"eighty":-0.54027,"marketCap":36397488},{"date":"2025-03-21","current":-0.995395,"twenty":-2.450334,"median":-0.992073,"eighty":-0.540384,"marketCap":35354442},{"date":"2025-03-28","current":-1.032134,"twenty":-2.449704,"median":-0.99303,"eighty":-0.540781,"marketCap":36659340},{"date":"2025-04-04","current":-0.78101,"twenty":-2.448759,"median":-0.991434,"eighty":-0.542601,"marketCap":32679811},{"date":"2025-04-11","current":-0.489987,"twenty":-2.448759,"median":-0.988448,"eighty":-0.542487,"marketCap":20502510},{"date":"2025-04-17","current":-0.606212,"twenty":-2.447266,"median":-0.987467,"eighty":-0.541932,"marketCap":25365734},{"date":"2025-04-25","current":-0.673105,"twenty":-2.441222,"median":-0.984507,"eighty":-0.54421,"marketCap":28164712},{"date":"2025-05-02","current":-0.572766,"twenty":-2.44037,"median":-0.982985,"eighty":-0.544868,"marketCap":23966245},{"date":"2025-05-09","current":-0.572766,"twenty":-2.438076,"median":-0.974508,"eighty":-0.544868,"marketCap":23966245},{"date":"2025-05-16","current":-0.507638,"twenty":-2.437958,"median":-0.970698,"eighty":-0.542962,"marketCap":22741693},{"date":"2025-05-23","current":-0.491238,"twenty":-2.437958,"median":-0.96416,"eighty":-0.540232,"marketCap":22006961},{"date":"2025-05-30","current":-0.478742,"twenty":-2.437958,"median":-0.960929,"eighty":-0.53526,"marketCap":21447165},{"date":"2025-06-06","current":-0.652659,"twenty":-2.43115,"median":-0.951307,"eighty":-0.53526,"marketCap":29238478},{"date":"2025-06-13","current":-0.584434,"twenty":-2.426362,"median":-0.945711,"eighty":-0.536811,"marketCap":26182063},{"date":"2025-06-20","current":-0.629551,"twenty":-2.426362,"median":-0.945267,"eighty":-0.538017,"marketCap":28203253},{"date":"2025-06-27","current":-0.646886,"twenty":-2.425739,"median":-0.940293,"eighty":-0.539819,"marketCap":28979864},{"date":"2025-07-03","current":-0.650536,"twenty":-2.423811,"median":-0.935828,"eighty":-0.540308,"marketCap":29143361},{"date":"2025-07-11","current":-0.671521,"twenty":-2.416976,"median":-0.929158,"eighty":-0.540384,"marketCap":30083470},{"date":"2025-07-18","current":-0.607654,"twenty":-2.411351,"median":-0.926272,"eighty":-0.54098,"marketCap":27222270},{"date":"2025-07-25","current":-0.587125,"twenty":-2.406425,"median":-0.920451,"eighty":-0.542149,"marketCap":26302599},{"date":"2025-08-01","current":-0.65966,"twenty":-2.401897,"median":-0.915146,"eighty":-0.543067,"marketCap":29552104},{"date":"2025-08-08","current":-0.641412,"twenty":-2.398107,"median":-0.914022,"eighty":-0.543826,"marketCap":28734618},{"date":"2025-08-15","current":-0.976652,"twenty":-2.395386,"median":-0.913096,"eighty":-0.544323,"marketCap":42092726},{"date":"2025-08-22","current":-0.963259,"twenty":-2.391278,"median":-0.915146,"eighty":-0.545732,"marketCap":41515505},{"date":"2025-08-28","current":-1.108521,"twenty":-2.389034,"median":-0.92015,"eighty":-0.546796,"marketCap":47776132}],"updateTime":1756509502108},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TPST\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2526565220","title":"Tempest Therapeutics Cut to Sector Perform From Sector Outperform by Scotiabank","url":"https://stock-news.laohu8.com/highlight/detail?id=2526565220","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526565220?lang=en_us&edition=fundamental","pubTime":"2025-04-10 20:23","pubTimestamp":1744287780,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TPST/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 10, 2025 08:23 ET (12:23 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","TPST"],"gpt_icon":0},{"id":"2526653735","title":"HC Wainwright Downgrades Tempest Therapeutics to Neutral From Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2526653735","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526653735?lang=en_us&edition=fundamental","pubTime":"2025-04-10 20:14","pubTimestamp":1744287261,"startTime":"0","endTime":"0","summary":"HC Wainwright Downgrades Tempest Therapeutics to Neutral From Buy","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LENZ","TPST"],"gpt_icon":0},{"id":"2526496193","title":"BUZZ-Tempest rises as company eyes potential merger to advance liver cancer drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2526496193","media":"Reuters","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526496193?lang=en_us&edition=fundamental","pubTime":"2025-04-10 05:12","pubTimestamp":1744233159,"startTime":"0","endTime":"0","summary":"BUZZ-Tempest rises as company eyes potential merger to advance liver cancer drug** Shares of cancer drug developer Tempest Therapeutics TPST.O rise ~9% to $7.79 in extended trading** TPST says it is exploring strategic alternatives, such as mergers or partnerships, to advance its cancer treatment programs** Company's pipeline includes its lead liver cancer drug, amezalpat, and TPST-1495, a treatment for familial adenomatous polyposis, a rare genetic disorder** Amezalpat received both Orphan Drug and Fast Track designations from the US FDA** As of last close, stock down 34% YTD","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250409:nL3N3QN280:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TPST"],"gpt_icon":0},{"id":"2526346401","title":"Tempest Therapeutics Seeks Partner as It Explores Strategic Alternatives","url":"https://stock-news.laohu8.com/highlight/detail?id=2526346401","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526346401?lang=en_us&edition=fundamental","pubTime":"2025-04-10 05:01","pubTimestamp":1744232460,"startTime":"0","endTime":"0","summary":"Tempest Therapeutics is exploring strategic alternatives for the business, including mergers, partnerships, acquisition, joint ventures and licensing agreements.Shares rose 9.2% to $7.81 in post-market trading. Through Wednesday's close, the stock has fallen 85% over the past 12 months.The clinical-stage biotechnology company on Wednesday said that it hired MTS Health Partners as financial adviser for its strategic evaluation process.\"Given the positive data and commercial potential with this [company] pipeline, as well as the clearance from the Food and Drug Administration on the lead program's pivotal study, we believe this is a rare opportunity for a partner,\" Chief Executive Stephen Brady said.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","BK4139","TPST","BK4007"],"gpt_icon":0},{"id":"2526034561","title":"Tempest Therapeutics to explore strategic alternatives","url":"https://stock-news.laohu8.com/highlight/detail?id=2526034561","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526034561?lang=en_us&edition=fundamental","pubTime":"2025-04-10 04:35","pubTimestamp":1744230940,"startTime":"0","endTime":"0","summary":"Tempest Therapeutics (TPST) announced that the company plans to explore a full range of strategic alternatives to advance its clinical stage progra...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tempest-therapeutics-to-explore-strategic-alternatives?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tempest-therapeutics-to-explore-strategic-alternatives?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","TPST","BK4139","LENZ"],"gpt_icon":0},{"id":"2526498953","title":"Tempest Announces Plan to Explore Strategic Alternatives to Advance Promising Pipeline of Clinical Oncology Assets and Maximize Stockholder Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2526498953","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526498953?lang=en_us&edition=fundamental","pubTime":"2025-04-10 04:30","pubTimestamp":1744230600,"startTime":"0","endTime":"0","summary":"Amezalpat  is Phase 3-ready: completed FDA and EMA interactions for first-line pivotal study in hepatocellular carcinoma ; global investigator support in place. Awarded both Orphan Drug & Fast Track designations for amezalpat based on positive randomized Phase 2 data in first-line HCC. Received FDA “Study May Proceed” letter for TPST-1495 in a Phase 2 trial for the treatment of familial adenomatous polyposis ; data expected 2026. The company has not set a timetable for completion of the process for evaluating strategic alternatives and does not intend to disclose further developments or guidance on the status of its programs or the process for evaluating strategic alternatives unless and until it is determined that further disclosure is appropriate or necessary. No agreement providing for any transaction has been reached and there can be no assurances that any transaction will result from the process for evaluating strategic alternatives. If the process for evaluating strategic alterna","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/tempest-announces-plan-explore-strategic-203000016.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4202","HCC","OS","NCI","BK4097","TPST","BK4006","BK4139"],"gpt_icon":0},{"id":"2525048724","title":"BRIEF-Tempest Therapeutics Announced 1-For-13 Reverse Stock Split","url":"https://stock-news.laohu8.com/highlight/detail?id=2525048724","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525048724?lang=en_us&edition=fundamental","pubTime":"2025-04-07 20:58","pubTimestamp":1744030735,"startTime":"0","endTime":"0","summary":"BRIEF-Tempest Therapeutics Announced 1-For-13 Reverse Stock SplitApril 7  - Tempest Therapeutics Inc TPST.O:TEMPEST THERAPEUTICS INC - ON APRIL 4, ANNOUNCED 1-FOR-13 REVERSE STOCK SPLIT - SEC FILINGTEMPEST THERAPEUTICS INC - REVERSE STOCK SPLIT EFFECTIVE APRIL 8, 2025 - SEC FILINGSource text: [ID:n0001193125-25-073987]Further company coverage: TPST.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250407:nFWN3QL054:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TPST","BK4139"],"gpt_icon":0},{"id":"2524979885","title":"Tempest Therapeutics treatment of FAP granted FDA orphan designation","url":"https://stock-news.laohu8.com/highlight/detail?id=2524979885","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524979885?lang=en_us&edition=fundamental","pubTime":"2025-04-01 03:00","pubTimestamp":1743447612,"startTime":"0","endTime":"0","summary":"Tempest Therapeutics (TPST)’ treatment of familial adenomatous polyposis was granted orphan designation by the FDA, according to a post to the agen...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tempest-therapeutics-treatment-of-fap-granted-fda-orphan-designation?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tempest-therapeutics-treatment-of-fap-granted-fda-orphan-designation?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LENZ","TPST"],"gpt_icon":0},{"id":"2523689468","title":"Scotiabank Reaffirms Their Buy Rating on Tempest Therapeutics (TPST)","url":"https://stock-news.laohu8.com/highlight/detail?id=2523689468","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523689468?lang=en_us&edition=fundamental","pubTime":"2025-03-29 01:46","pubTimestamp":1743183993,"startTime":"0","endTime":"0","summary":"In a report released today, George Farmer from Scotiabank maintained a Buy rating on Tempest Therapeutics (TPST – Research Report), with a price ta...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/scotiabank-reaffirms-their-buy-rating-on-tempest-therapeutics-tpst-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/scotiabank-reaffirms-their-buy-rating-on-tempest-therapeutics-tpst-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TPST"],"gpt_icon":0},{"id":"2523768941","title":"Piper Sandler Reaffirms Their Buy Rating on Tempest Therapeutics (TPST)","url":"https://stock-news.laohu8.com/highlight/detail?id=2523768941","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523768941?lang=en_us&edition=fundamental","pubTime":"2025-03-29 01:45","pubTimestamp":1743183948,"startTime":"0","endTime":"0","summary":"In a report released today, Edward Tenthoff from Piper Sandler reiterated a Buy rating on Tempest Therapeutics (TPST – Research Report), with a pri...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/piper-sandler-reaffirms-their-buy-rating-on-tempest-therapeutics-tpst?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/piper-sandler-reaffirms-their-buy-rating-on-tempest-therapeutics-tpst?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TPST"],"gpt_icon":0},{"id":"2523689447","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Kodiak Sciences (KOD), Tempest Therapeutics (TPST) and EDAP TMS (EDAP)","url":"https://stock-news.laohu8.com/highlight/detail?id=2523689447","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523689447?lang=en_us&edition=fundamental","pubTime":"2025-03-29 01:40","pubTimestamp":1743183617,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Kodiak Sciences (KOD – Research Report), Tempest T...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-kodiak-sciences-kod-tempest-therapeutics-tpst-and-edap-tms-edap?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-kodiak-sciences-kod-tempest-therapeutics-tpst-and-edap-tms-edap?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","HCSG","EDAP","BK4139","TPST","BK4082","KOD","BK4505"],"gpt_icon":0},{"id":"2522573984","title":"Tempest Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2522573984","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522573984?lang=en_us&edition=fundamental","pubTime":"2025-03-28 20:00","pubTimestamp":1743163255,"startTime":"0","endTime":"0","summary":"Tempest Therapeutics Inc reports results for the quarter ended December 31 - Earnings SummaryTempest Therapeutics Inc TPST.OQ reported a quarterly adjusted loss of 31 cents per share for the quarter e","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250328:nL5N3QB0U8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TPST"],"gpt_icon":0},{"id":"2522266555","title":"William Blair Reaffirms Their Buy Rating on Tempest Therapeutics (TPST)","url":"https://stock-news.laohu8.com/highlight/detail?id=2522266555","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522266555?lang=en_us&edition=fundamental","pubTime":"2025-03-28 06:36","pubTimestamp":1743114992,"startTime":"0","endTime":"0","summary":"In a report released today, Matt Phipps from William Blair reiterated a Buy rating on Tempest Therapeutics (TPST – Research Report). The company’s ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/william-blair-reaffirms-their-buy-rating-on-tempest-therapeutics-tpst?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/william-blair-reaffirms-their-buy-rating-on-tempest-therapeutics-tpst?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TPST"],"gpt_icon":0},{"id":"2522853184","title":"Press Release: Tempest Reports Year End 2024 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2522853184","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522853184?lang=en_us&edition=fundamental","pubTime":"2025-03-28 04:10","pubTimestamp":1743106200,"startTime":"0","endTime":"0","summary":"-- Granted Both Orphan Drug & Fast Track designations for Amezalpat  for the treatment of patients with Hepatocellular Carcinoma . -- Announced Agreement with Roche to Support Advancement of Amezalpat Combination Therapy into First-Line HCC Pivotal Trial. -- Received FDA \"Study May Proceed\" letter for Phase 2 trial of TPST-1495 for the treatment of Familial Adenomatous Polyposis . \"2024 was another year filled with significant progress and milestone achievements that position Tempest for a successful future,\" said Stephen Brady, president and chief executive officer of Tempest. \"Despite challenging capital markets, our lean team excelled, reporting key OS data from the ongoing randomized Phase 2 trial of amezalpat in first-line hepatocellular carcinoma. As previously announced, we have secured broad regulatory agreement with both the FDA and EMA on the Phase 3 plan and received both Orphan Drug and Fast Track designations from the FDA. We also advanced our second clinical program, TPST","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HCC","BK4097","NCI","BK4202","BK4232","BK4006","BK4022","OS","R","TPST","BK4139"],"gpt_icon":0},{"id":"2522361315","title":"Jakarta to Deploy Nearly 3,000 Sanitation Officers to Anticipate Eid Holiday","url":"https://stock-news.laohu8.com/highlight/detail?id=2522361315","media":"Tempo","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522361315?lang=en_us&edition=fundamental","pubTime":"2025-03-27 23:23","pubTimestamp":1743089010,"startTime":"0","endTime":"0","summary":"TEMPO.CO, Jakarta -The Jakarta Environmental Agency is deploying 2,906 cleaning service officers to maintain the city during the night before Eid al-Fitr and the Eid holiday that follows. The officers will be stationed at various locations, including temporary waste disposal sites , tourist attractions, and public areas.The Head of the Jakarta Environmental Agency, Asep Kuswanto, stated that they have also prepared 89 units of automatic road sweepers, 35 bus toilets, and 20 portable toilets to support cleanliness operations during this period. \"We are allocating approximately 70 officers in each district,\" Asep said in a written statement on Thursday, March 27, 2025.","market":"hk","thumbnail":"https://statik.tempo.co/data/2023/09/12/id_1236432/1236432_720.jpg","type":0,"news_type":0,"thumbnails":["https://statik.tempo.co/data/2023/09/12/id_1236432/1236432_720.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://en.tempo.co/read/1991367/jakarta-to-deploy-nearly-3000-sanitation-officers-to-anticipate-eid-holiday","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tempo_highlight","symbols":["TPS.AU","BK4139","TPST"],"gpt_icon":0},{"id":"2519870181","title":"Tempest Therapeutics Inc  expected to post a loss of 25 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2519870181","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519870181?lang=en_us&edition=fundamental","pubTime":"2025-03-14 19:32","pubTimestamp":1741951926,"startTime":"0","endTime":"0","summary":"Tempest Therapeutics Inc  expected to post a loss of25cents a share - Earnings Preview Tempest Therapeutics Inc TPST.OQ TPST.O is expected to show no change in quarterly revenue when it reports  resul","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250314:nL8N3PX0VQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TPST"],"gpt_icon":0},{"id":"2519343839","title":"Tempest Therapeutics Says Familial Adenomatous Polyposis Trial Gets US FDA 'Study May Proceed' Notice","url":"https://stock-news.laohu8.com/highlight/detail?id=2519343839","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519343839?lang=en_us&edition=fundamental","pubTime":"2025-03-13 20:41","pubTimestamp":1741869668,"startTime":"0","endTime":"0","summary":"Tempest Therapeutics  said Thursday that the mid-stage clinical trial of TPST-1495 for the treatment of familial adenomatous polyposis has received a \"study may proceed\" letter from the US Food and Drug Administration.The clinical-stage company said the Cancer Prevention Clinical Trials Network will run the mid-stage study, which will start this year and funded by the National Cancer Institute Division of Cancer Prevention.Shares of the company were up more than 1% in recent premarket activity on Thursday.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LENZ","BK4139","TPST"],"gpt_icon":0},{"id":"2519683638","title":"BRIEF-Tempest gets FDA nod to begin mid-stage study of its therapy for colon cancer-causing genertic condition","url":"https://stock-news.laohu8.com/highlight/detail?id=2519683638","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519683638?lang=en_us&edition=fundamental","pubTime":"2025-03-13 20:20","pubTimestamp":1741868411,"startTime":"0","endTime":"0","summary":"BRIEF-Tempest gets FDA nod to begin mid-stage study of its therapy for colon cancer-causing genertic conditionMarch 13 (Reuters) - Tempest Therapeutics Inc TPST.O:FDA STUDY MAY PROCEED NOTICE RECEIVED","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250313:nTUA4G3QJC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TPST"],"gpt_icon":0},{"id":"2519356568","title":"FDA Study May Proceed Notice Received for Phase 2 Trial of TPST-1495 for the Treatment of Familial Adenomatous Polyposis (FAP)","url":"https://stock-news.laohu8.com/highlight/detail?id=2519356568","media":"GlobeNewswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519356568?lang=en_us&edition=fundamental","pubTime":"2025-03-13 20:00","pubTimestamp":1741867200,"startTime":"0","endTime":"0","summary":"Second clinical program entering Phase 2 with data expected 2026. BRISBANE, Calif., March 13, 2025  -- Tempest Therapeutics, Inc. , a clinical-stage biotechnology company developing first-in-class1 targeted and immune-mediated therapeutics to fight cancer, today announced that the Cancer Prevention Clinical Trials Network received a “Study May Proceed” letter from the U.S. Food and Drug Administration  to evaluate TPST-1495, the company’s novel dual receptor inhibitor of prostaglandin  signaling, in a Phase 2 clinical trial for the treatment of patients with Familial Adenomatous Polyposis .The Phase 2 study in patients with FAP will begin this year and will be run by the Cancer Prevention Clinical Trials Network and funded by the National Cancer Institute  Division of Cancer Prevention.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/fda-study-may-proceed-notice-120000300.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","TPST"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":39,"code":"91000000","status":"200"}]}}